首页> 美国卫生研究院文献>BMC Veterinary Research >Effect of intralesional platelet-rich plasma (PRP) treatment on clinical and ultrasonographic parameters in equine naturally occurring superficial digital flexor tendinopathies – a randomized prospective controlled clinical trial
【2h】

Effect of intralesional platelet-rich plasma (PRP) treatment on clinical and ultrasonographic parameters in equine naturally occurring superficial digital flexor tendinopathies – a randomized prospective controlled clinical trial

机译:病灶内富血小板血浆(PRP)治疗对马自然发生的浅表屈指肌腱病的临床和超声检查参数的影响–一项随机前瞻性对照临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundRegenerative and anti-inflammatory effects on tendinopathies have been attributed to blood-derived biologicals. To date the evidence for the efficacy of autologous platelet-rich plasma (PRP) treatment of naturally occurring equine tendinopathies is limited. The purpose of this placebo-controlled clinical trial was to describe the effect of a single treatment of equine superficial digital flexor tendon (SDFT) disease with PRP on clinical and ultrasonographic parameters. Twenty horses with naturally occurring tendinopathies of forelimb SDFTs were randomly assigned to the PRP-treated group (n = 10) or control group (n = 10) after clinical and ultrasonographic examination. The SDFTs received an intralesional treatment with autologous PRP or were injected with saline, respectively (day 0). All horses participated in a standardized exercise programme and were re-examined clinically, with B-mode ultrasonography (5 times at regular intervals) and ultrasound tissue characterization (week 12 and 24 after treatment) until week 24. Long-term performance was estimated via telephone inquiry.
机译:背景技术对肌腱病的再生和抗炎作用已经归因于血液来源的生物。迄今为止,自体富血小板血浆(PRP)治疗天然马肌腱病的功效的证据有限。该安慰剂对照临床试验的目的是描述采用PRP单一治疗马蹄浅指屈肌腱(SDFT)疾病对临床和超声检查参数的影响。在临床和超声检查后,将二十只具有自然发生的前肢SDFT肌腱病病患的马随机分为PRP治疗组(n = 10)或对照组(n assigned = 10)。 SDFTs接受自体PRP的病灶内治疗或分别注射盐水(第0天)。所有马匹都参加了标准化的锻炼计划,并经过了B型超声检查(定期间隔5次)和超声组织表征(治疗后的第12周和第24周)直至第24周的临床再检查。通过电话查询。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号